Login
$CAMP
$3.65 +$0.44 (13.71%) Close

$CAMP 3 SEC Filings

Filed On Filing
03 Apr 2026 Form 3: MacLean Michael F, Director

No securities owned

10 Oct 2025 Form 3: Tardiff Daniel, Chief Scientific Officer
19 Mar 2025 Form 3: Williams Douglas E, Director

No securities owned

19 Mar 2025 Form 3: Stewart Murray, Director

No securities owned

15 Oct 2024 Form 3: Polaris Partners Gp X, L.l.c., 10% owner and 2 others

Holds 909,090 shares of Common Stock

10 Oct 2024 Form 3: Polaris Management Co. VII, L.l.c., 10% owner and 2 others
10 Oct 2024 Form 3: Enavate Sciences GP, Llc, 10% owner and 1 other
10 Oct 2024 Form 3: Northpond Ventures Ii GP, Llc, 10% owner and 4 others
10 Oct 2024 Form 3: Ah Equity Partners Bio I, L.l.c., 10% owner and 3 others
10 Oct 2024 Form 3: 5AM Partners VI, Llc, 10% owner and 4 others
10 Oct 2024 Form 3: Maricich Yuri, Chief Medical Officer
10 Oct 2024 Form 3: Mandel-Brehm Josh, Director

Holds 271,752 shares of Common Stock

10 Oct 2024 Form 3: Gold Kelly, Chief Financial Officer

Holds 61,817 shares of Common Stock

10 Oct 2024 Form 3: Nashat Amir, Director
10 Oct 2024 Form 3: Schwab Andrew J., Director
10 Oct 2024 Form 3: Bumcrot David, Chief Scientific Officer

Holds 61,741 shares of Common Stock

10 Oct 2024 Form 3: Holtzman Steven H, Director

Holds 100,029 shares of Common Stock

10 Oct 2024 Form 3: Chakravarty Ingo, Director

No securities owned

10 Oct 2024 Form 3: Higgins Michael J, Director

Holds 28,739 shares of Common Stock

10 Oct 2024 Form 3: Ragan Paula, Director

Holds 20,232 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support